Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science Startup Investors in Middle East in November 2024

Last updated: Nov 2024 A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Middle east. We rank investors based on the number of investments they made in Life science companies from Middle east. We update this investor list every month.

Top 50 Life Science Startup Investors in Middle East in November 2024

Investor	Life Science Middle East investments
Sapir Venture Partners	4
Integra Holdings	4
Egypt Ventures	4
TRANGELS	4
Israel Innovation Authority	3
Pitango VC	3
Neo Ventures	3
OrbiMed	3
Minrav	2
PeakBridge	2
Averroes Ventures	2
Arancia International	2
fresh.fund	2
FutuRx	2
SOSV	2
Pontifax	2
Grove Ventures	2
Oryx Fund	2
aMoon Fund	2
Cairo Angels	2
Takeda Ventures	2
LoftyInc Capital	2
Ahmed Abdelhamid	2
Genesis Park	2
First Star Ventures	2
Johnson & Johnson Robotics and Digital Solutions	2
Endure Capital	2
Cancer Focus Fund	2
Trust Ventures	1
Hult Alumni Angels	1
Talisman Capital Partners	1
TPY Capital	1
RMGP Biopharma Investment Fund	1
Boehringer Ingelheim Venture Fund	1
Aries Holding BV	1
OTV	1
Pfizer	1
HBL Hadasit Bio Holdings	1
Knuru Capital	1
Forbion Capital Partners	1
Ibtikar Fund	1
e& capital	1
Khwarizmi Ventures	1
Okan Erol	1
Alexandria Fund	1
Dementia Discovery Fund	1
Sectoral Asset Management	1
Ali Rıza Babaoğlan	1
Alex Angels	1
Bio Capital Impact Fund	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Early Stage VC

Investment focus

Software, Biotechnology, Machine Learning
Seed, Pre-Seed, Series A
Israel, United States, United Kingdom

Portfolio highlights

Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Investment focus

Biotechnology, Pharmaceutical, Life Science
Seed, Series B, Series F
Israel

Portfolio highlights

BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria

Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.

Investment focus

Software, Information Technology, E-Commerce
Seed, Pre-Seed, Series A
Egypt, United States, The Netherlands

Portfolio highlights

Educatly — We help you get into the University of your dreams. We are the only platform with all the information you need to Study Abroad
Gahez Market — Gahez Market Online store
Synapse Analytics — We build data science and AI solutions for streamlined operations and data driven decisions. Synapse Analytics, enabling a smarter world.

Early Stage Investment Fund and Network

Investment focus

Biotechnology, Energy, Manufacturing
Seed, Pre-Seed, Angel
Turkey, United States, Estonia

Portfolio highlights

& New Me — Explore the best aesthetic treatments in Turkey with New Me. Book a consultation, read reviews, and find the right doctor for your beauty journey.
Winfluencer — Winfluencer is a platform for automated digital influencer marketing. Their solutions are machine learning, augmented reality, image processing, data analytics, social media analytics, and fraud detection. Winfluencer connects thousands of e-commerce sites through a single platform and an automated system. Because of the new generation affiliatemarketing approach, this system enables users to generate long-term income. Its transparent structure allows both users and the e-commerce site to track sales generated by their interactions.
Nanomik Biotechnology — Biochemistry leading change in life sciences. With our proprietary technologies, we develop solutions for Crop Health, Animal Health and Food preservation.

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Investment focus

Health Care, Medical Device, Biotechnology
Grant, Seed, Pre-Seed
Israel, United States, Mali

Portfolio highlights

Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
Lavie bio — Improve food quality, agricultural sustainability and productivity through the introduction of microbiome based ag-biological products.
Eretz Angels — Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Investment focus

Software, Health Care, Information Technology
Series A, Series B, Series C
Israel, United States, China

Portfolio highlights

Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

Investment focus

Software, Artificial Intelligence, Aerospace
Seed, Funding Round, Series A
Israel, United Kingdom, Estonia

Portfolio highlights

EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

enGene — enGene is a developer of a mucosal immunotherapy platform designed to treat inflammatory bowel disease and diabetes. The company's mucosal immunotherapy platform has developed a flexible nucleotide delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expressionlevels, enabling physicians and doctors to regenerate physiologic, meal-regulated insulin secretion from the gut of subjects with diabetes.
Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
Lomond Therapeutics — Lomond Therapeutics is a pharmaceutical firm that discovers and develops small molecule inhibitors that target escape variants in hematologic malignancies.

Minrav provides engineering and construction services.

Investment focus

Health Care, Hospital, Wellness
Series A, Funding Round
Israel, Malaysia

Portfolio highlights

iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.

PeakBridge is an Alternative Investment Fund Manager and Investment Services Firm specialized in FoodTech.

Investment focus

Food and Beverage, Food Processing, Health Care
Seed, Series A, Funding Round
Israel, United States, United Kingdom

Portfolio highlights

Mondra — AI-driven environmental insights platform that supports food system players to accelerate Scope 3 progress, reduce the cost of Net Zero, and drive competitive advantage.
WNWN Food Labs — We're WNWN Food Labs and we love food. We're creating delicious, sustainable and ethical alternatives to unsustainable and ethically dubious foods. We're starting with cacao-free chocolate. Changing chocolate? It's Win-Win #alt-chocolate #altchocolate #alt-universe #altuniverse #alt-protein
The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.

Averroes Ventures helps and invests in entrepreneurial teams seeking to transform big ideas into game-changing companies. Averroes Ventures' team possesses years of combined experience in global business operation and management across a multitude of sectors to help achieve visions.

Investment focus

Transportation, Logistics, Delivery
Seed, Convertible Note
Egypt, United Arab Emirates

Portfolio highlights

ILLA — Digital trucking and delivery platform powered by reliable drive to enable businesses with different volumes handle and optimize their trucking and logisitcs processes effeciently.
Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Khazenly — Khazenly is an on-demand digital warehousing and fulfillment management platform that provides an omnichannel solution to help merchants digitize their businesses.

Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.

Investment focus

Health Care, Biotechnology, Life Science
Series A, Series B, Funding Round
Israel, United States, Malaysia

Portfolio highlights

NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Investment focus

Health Care, FinTech, Education
Seed, Pre-Seed, Series A
Israel, United States, Norway

Portfolio highlights

enso — enso offers AI-powered bot bundles to automate your marketing strategy. Perfect for small business owners, our bots handle social media, SEO, lead generation & much more. Start with a 7 days free trial or talk with one of our marketing experts today.
Carbon Blue — Carbon Blue is developing an 'ocean-capture' scalable method for removing CO2 from the atmosphere. The company was founded by Iddo Tsur and Dan Deviri.
Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Investment focus

Biotechnology, Life Science, Biopharma
Seed, Funding Round
Israel

Portfolio highlights

Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...

Investment focus

Artificial Intelligence, Machine Learning, Software
Seed, Series A, Series B
Israel, United States

Portfolio highlights

Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
Wing Cloud — Wing Cloud tames cloud complexity through a unified programming and operational model that works across all providers and services.
Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.

Oryx Fund is a MENA-focused Investment fund from Hambro Perks. Investing in game-changing early-stage technology companies at late Seed and Series A, led by outstanding entrepreneurs in sectors we have deep expertise such as Fintech, Healthtech, Enterprise tech, Logistics tech, and Edtech.

Investment focus

Software, Information Technology, SaaS
Seed, Pre-Seed, Series A
United Arab Emirates, Saudi Arabia, Egypt

Portfolio highlights

Growdash — Growdash is a business intelligence and analytics tool built specifically for restaurants to support profitable growth strategic decisions across online sales channels.
Penny Software — Simple. Spending. Software.As above. But, more specifically, penny is a cloud-based Procure-To-Pay system. penny helps you digitize and manage your full procurement cycle from request to approval. Manage RFQs to vendors, compare quotations, send POs and even payment. penny was designed to make things easy and consolidate all of yourorganization’s spending needs into one intelligent system
Merit Incentives — Merit Incentives provides gifts, rewards, and engagement strategies using innovative technologies in the MENA region.

aMoon is a leading healthtech & life sciences venture capital firm.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Israel, Switzerland

Portfolio highlights

AltruBio — AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases.AltruBio International in Delaware with principal office in SFO Bay Area California is a biopharmaceutical company integrated globally and virtually to develop targeted antibody therapeutics for the treatment ofcancer and immune-related inflammatory diseases.With its R&D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discovery and development of novel therapeutics for unmet medical needs.Their R&D scientists built an efficient discovery platform to identify and validate novel antibody therapeutics.Currently, AbGenomics has several potential therapeutic antibodies targeting autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors in various development stages.
Air Doctor — Air Doctor provides a global medical network and makes it accessible for anyone looking for private medical care.
Eleos Health — Automate documentation, alleviate provider burnout, and elevate care quality with the CareOps Automation platform from Eleos Health.

Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.

Investment focus

E-Commerce, Mobile, Marketplace
Seed, Angel, Pre-Seed
Egypt, United States, Lebanon

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Sprints — home page Description
The Fashion Kingdom — Fashion, Sneakers for men, women, and kids

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.

LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........

Investment focus

FinTech, Financial Services, Software
Seed, Pre-Seed, Series A
Nigeria, United States, Egypt

Portfolio highlights

Mtor — Mtor is an online marketplace that is reshaping the automotive aftermarket and provides sophisticated technology solutions.
EMTECH — EMTECH provides solutions for Digital Currency regulatory compliance, development and management to help Central Banks and FinTechs build, run and manage modern financial systems.
Terragon Group — Terragon is a leading Data and Marketing Technology company that uses data and analytics to help companies focused in Africa, intelligently connect at scale to their customers. We use an aggregation of online and offline data, and predictive scoring to help brands, marketing agencies and platforms accurately target people across channels anddevices. Headquartered in Lagos; Nigeria, we also have a presence in Kenya, South Africa, Ghana and India.

Ahmed Abdelhamid is Partner at Endure Capital. He attended Vlerick Business School.

Investment focus

Aerospace, Biopharma, Life Science
Seed, Convertible Note
Egypt, United States

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Wright Electric, Inc. — Wright Electric, Inc. is building technologies for large commercial airplanes. The company is currently developing their flagship Airplane, the Wright 1, which will be a 186-seat single aisle airliner with an 800 mile range. The company hopes to achieve entry to service for the Wright 1 by 2030 and is working with commercial airlines includingeasyJet and VivaAerobus. In addition to the newly announced U.S. DOE’s ARPA-E funding, the company is funded by Y Combinator, the Clean Energy Trust and venture funds.

Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.

Investment focus

Manufacturing, Construction, Health Care
Private Equity, Debt Financing, Funding Round
United States, Israel

Portfolio highlights

The Good Feet Store — Discover comfort and foot pain relief with The Good Feet Store arch support inserts. Clinically proven - improve body alignment and overall foot health.
WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
Conditioned Air — Conditioned Air is South Florida's premier air conditioning contractor with 60 years of experience. Serving Naples, Venice, Ft. Myers, Englewood, Port Charlotte, Sarasota, Bradenton & Surrounding Areas.

Investing with conviction in visionary, technical founders inventing the future.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Pre-Seed, Series A
United States, Canada, Israel

Portfolio highlights

Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
Phaseshift Technologies — Phaseshift Technologies is developing a Computational Materials Engineering (CME) platform to help accelerate the Research and Development of High-Performance Alloys. The CME platform is driven by Quantum Chemistry calculations and aided by Machine Learning based predictive algorithms.

Healthcare innovation wherever it originates.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, Israel, United Kingdom

Portfolio highlights

Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.

Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.

Investment focus

Health Care, Software, E-Commerce
Seed, Series A, Series B
Egypt, United States, United Kingdom

Portfolio highlights

Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
Pylon — Reliable smart energy solutions within the reach of emerging markets.
Almentor — almentor.net is a cutting-edge continuous e-learning platform curating top-rated video-based training programs delivered by leading subject matter experts and accessible through B2C and B2B channels to serve the needs of Arabs across the world. The platform was officially launched in January 2018 and currently offers the biggest Arabic high qualitycontinuous learning video library in the world, including paid courses, free talks, crash courses and books, primarily in Arabic.

Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients. The company was founded by Ross Barrett.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Seed, Series A
Israel, United States, Germany

Portfolio highlights

Eisbach Bio — Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes. Screening and cellular platforms are yielding first-in-class inhibitors to directly target the key vulnerability found in genetically defined tumors. It is founded in 2019 and is based in Martinsried, Bavaria.
March Biosciences — Transforming Patient Care by Unlocking New Target Spaces March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity
Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.

Trust Ventures is a venture capital firm that focuses on startups and provides knowledge and expertise in incumbent-heavy industries. The firm was founded in 2018 and is based in Austin, Texas, United States.

Investment focus

Information Technology, Health Care, Software
Seed, Series A, Series B
United States, Brazil, Israel

Portfolio highlights

Base Power — Base provides a battery-powered home energy service so you can enjoy power without interruption and save money. Now available in select regions of Texas.
Harbor — Harbor offers the first and only baby monitoring system with a dedicated, local Monitor that works without internet and securely connects to the cloud if and when you want it to, allowing you to access remotely with failsafe notifications. Learn why Harbor is better than Nanit & Owlet at harbor.co!
Valkyrie Andromeda — Andromeda is a decision-intelligence platform that develops unbiased strategic plans and hallucination-free processes based on a single prompt—designed for national security.

Hult Alumni Angels

Investment focus

Biopharma, Life Science, Biotechnology
Seed
Egypt

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.

Talisman Capital Partners operates as a private investment company.

Investment focus

Information Services, Pet, News
Series A, Seed, Series B
United States, Israel, Hong Kong

Portfolio highlights

Bond Vet — We offer compassionate, thorough, & friendly pet care in a warm, comfortable environment. Walk in or book online.
Prilenia — Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.The company wasfounded in 2018 and is based in Israel, the Netherlands, and Boston.
qServe Communications — I found a great domain name for sale on Dan.com. Check it out!

TPY Capital is a Tel Aviv based early state VC, investing in some of Israel’s most talented entrepreneurs. They are active investors who typically lead rounds in the areas we invest in, which include data and analytics, digitization and human augmentation, fintech, and frontier tech such as quantum computing.

Investment focus

Software, Artificial Intelligence, Big Data
Seed, Series A, Series B
Israel, United States, France

Portfolio highlights

Tabnine — Tabnine is an AI code-completion tool that helps developers worldwide write better code faster.
Kodem Security — Providing users with runtime intelligence to grasp the relevant application risks.
DOT Compliance — Dot Compliance offers the industry's first ready to use Quality Management Solution. Dot Compliance solutions include an extensive set of off-the-shelf ready eQMS and compliance pre-configured processes that include full project validation services and product validation packages. Introducing a true eQMS paradigm shift, Dot Compliance offersthe industry’s most cost-effective quality and compliance management solution available, allowing life science customers around the world to quickly deploy flexible and scalable solutions.

RMGP Biopharma Investment Fund is an investment Fund

Investment focus

Biotechnology, Biopharma, Health Care
Seed, Series B, Funding Round
Israel

Portfolio highlights

Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.

financial holding company / investments

Investment focus

FinTech, Finance, Payments
Seed, Pre-Seed
The Netherlands, Israel

Portfolio highlights

Wakuli — It's called specialty coffee. Roasted lighter to enhance all the exciting flavours. To really taste them it's important to drink fresh. That's why we send our mailbox-friendly coffee within one week after roasting. And always with a better price for the farmers - thanks to you.
Diptera — Developing technology to fight mosquitoes with mosquitoes.
Flow — Flow is FinTech 3.0: It let's you automate payments between your bank accounts and wallets. Based on triggers and actions you can transfer your money automatically to the accounts you choose. Use Flow to automate a budgetting system, your investing, buying crypto or to distribute your money the way you like it. Where the previous generationpayment companies needed to build and maintain expensive payment rails, Flow focusses on leveraging Open Banking. People trust Flow to help with their cashflow automation.

OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.

Investment focus

Health Care, Medical, Artificial Intelligence
Series A, Series B, Seed
United States, Israel, Ghana

Portfolio highlights

Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.

Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that havethe potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Post-IPO Equity, Series A, Seed
United States, Israel, France

Portfolio highlights

CytoReason — CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases,reduce development costs and increase the likelihood of approval. To date, six of the world’s top ten pharma companies use CytoReason’s technology.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Series A, Series B
Israel

Portfolio highlights

ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.

Based out of Dubai, Knuru pursues equity and credit opportunities in fintech and marketplaces across the GCC, Africa and Southern Europe. The management is led by a team of investors and entrepreneurs bringing to venture capital extensive cross-asset class experience dedicated to supporting high growth businesses.

Investment focus

E-Commerce, Information Technology, Financial Services
Series A, Funding Round, Series C
United Arab Emirates, Spain, Kenya

Portfolio highlights

Savana — Transform EMR into Deep-Real World Evidence with a scientific methodology that applies Artificial Intelligence (AI) to EMR free-text.
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
The Giving Movement — Sustainable Activewear & Streetwear Clothing | Made in UAE | $4 per item donated to charity | Gym Clothing & Workout Clothes

Impacting the future of medicine.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, United Kingdom, The Netherlands

Portfolio highlights

Aiolos Bio — Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by anaccomplished team with decades of drug development experience and leadership in the biotech industry.
Tessellate BIO — Tessellate BIO is redefining synthetic lethality in cancer beyond homologous recombination deficiency, turning cancer patients into cancer surivivors.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

Ibtikar (Innovation, in Arabic) is a disruptive fund that will invest in innovative Palestinian companies. Ibtikar’s investments begin at the seed level through local accelerators, continue in post-acceleration phases and can also include series A investments in its portfolio companies. Through this investment strategy we aim to close a criticalfunding gap between acceleration and VC and other later-stage investors. Our goal is to maximize return for our investors by helping high-potential Palestinian companies answer regional and global needs. We will do this through direct support from our management team and select group of advisors, and will leverage the strong network of our investors and partners for the benefit of each of our portfolio companies.

Investment focus

Artificial Intelligence, E-Commerce, Information Technology
Seed, Pre-Seed, Funding Round
Palestinian Territory, United States, Jordan

Portfolio highlights

DataQueue — Discover essential strategies for AI readiness with DataQueue. Learn how to prepare your business, choose the right AI tools, and develop a strategic AI plan for future success
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
Algebra Intelligence — Algebra Intelligence is a software development firm that integrates artificial intelligence solutions into the energy sector by providing comprehensive asset performance management, proactive notifications, predictive maintenance, and energy forecast.

e& capital invest in the ideas and people that are making a better, alternate future for all.

Investment focus

Video, Information Technology, Social Media
Series A, Series B, Series C
United Arab Emirates, India, United States

Portfolio highlights

Almentor — almentor.net is a cutting-edge continuous e-learning platform curating top-rated video-based training programs delivered by leading subject matter experts and accessible through B2C and B2B channels to serve the needs of Arabs across the world. The platform was officially launched in January 2018 and currently offers the biggest Arabic high qualitycontinuous learning video library in the world, including paid courses, free talks, crash courses and books, primarily in Arabic.
Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
MaxByte Technologies — Transform your industry with Industry X.0, the digital revolution driving innovation and efficiency. Unlocking the potential of manufacturing

Khwarizmi Ventures is a venture capital firm that seeks investments in startups with a passion for algorithms. It seeks to help create their vision, as they embark on a journey together that aligns their goals to improve quality of life using technology powered by algorithms. .

Investment focus

E-Commerce, FinTech, Software
Seed, Series A, Pre-Seed
Saudi Arabia, Egypt, United Arab Emirates

Portfolio highlights

Yalla Plus — Yalla Plus offers QR-based digital menu solutions for restaurants, featuring integrated payments and easy menu management.
Bluworks.io — Bluworks.io is a HRTech SaaS platform offers cloud-based solutions.
Simplified Financial Solutions Company — Simplified Financial Solutions Company offers startups and SMEs financial management solutions including the ability to issue virtual and physical corporate cards, manage spending and automate expense reporting.

Okan co-founded Wordego and as CEO leads the company’s strategic, executive and managerial efforts. His executive management experience includes working as a Business Development Manager for French Chamber of Commerce, CEO for Imerys Minerals, CEO for Esen Minerals, and CEO for Steno Energy. Okan holds a BS degree in Computer Engineering fromGalatasaray University, an MBA from Sorbonne University and a PhD degree in Finance & Banking from Kadir Has University.

Investment focus

Biotechnology, AgTech, Ad Exchange
Seed, Angel, Pre-Seed
Turkey, United States

Portfolio highlights

WORDEGO — Wordego is a Programmatic Ad Exchange Platform for Advertisers and Publishers. Wordego provides advertisers to target consumers surfing on the publisher websites, and show them personalized digital ads and coupons. Wordego provides advertisers to acquire, convert, and re-engage customers on the internet, and enables publishers to manage andmonetize their websites’ advertising inventory.
Nanomik Biotechnology — Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment.
MD Research & Development — MD Research & Development are into research and development of innovative products and methods needed in the field of radiation oncology.

Alexandria Fund

Investment focus

Biopharma, Life Science, Biotechnology
Seed
Egypt

Portfolio highlights

Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

Investment focus

Biotechnology, Health Care, Therapeutics
Seed, Series A, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
AstronauTx — AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
Violet Therapeutics — Violet Therapeutics is a healthcare company that operates in stealth mode.

Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series C, Post-IPO Equity
United States, United Kingdom, France

Portfolio highlights

CurvaFix — Curvafix is the only intramedullary implant that follows the natural curvature of the pelvis. Continue reading to learn how the Curvafix implant works!
Phagenesis — Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "corticalremapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.
LENZ Therapeutics — LENZ Therapeutics is is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes.

I am a business professional since 2008 and a financial investor since 2015, having strategic positions in several scale-up tech companies/startups and real-estate assets. I continue to invest in the tech domain with a focus on SaaS solutions for B2B and B2C markets, and real estate options in developing markets with ROI targets.Grow inEMEA, the company I started in 2015, focuses on East Europe, Turkey, and the Middle East markets mostly for tech and real estate options and portfolio management. Also, my team provides market access services to Baltics, Turkey, and UAE / Saudi and gives investment advisory services.Prior to the investment focus, I worked in Linkedin EMEA Headquarter where I hold Director of Turkish Speaking Territory in Dublin, Ireland. Before, I have been with SAP AG and IBM in Turkey. I also give speeches at local and global investment events. I gave keynotes on ARAB NET in Lebanon, IT Arena in Ukraine, Rise Up Summit in Egypt, and NEXT in Germany. I also spoke at several closed corporate events of Roche, VESTEL, SAP AG, DenizBank, Turkish Economy Ministry, Turkish Exporters Assembly, Bakioğlu Holding, and AGT.Now, I am living in Tallinn, Estonia.Email: alib@growinemea.com Web: https://alibabaoglan.com Photos: https://gie.investments/my-photos

Investment focus

TV, CRM, Apps
Seed, Pre-Seed
Turkey

Portfolio highlights

Ekmob — Ekmob creates mobile projects for companies which have mobile field teams and operations.Companies with mobile teams and field operations have some common problems such as inefficiency in management of mobile teams, communication difficulties, inability to get instant data from field, offline mobile team on the field. All these problems lead tolack or deficiency in decision-support systems.
N'oluyo — N’oluyo is a TV program-based social platform and is your favorite buddy while watching TV.
Kahvegibikahve — Kahvegibikahve started with a crowdfunding campaign to make brewing real coffee easy and available everywhere. With high quality coffee beans and special Fiber Filtre™, your coffee is brewed properly, and without any hassle, you enjoy it.

Alex Angels is an investment management company that helps investors to invest in early-stage companies with strong management teams. The company specializes in the fields of financial services, financial exchange, and investments. Alex Angels was founded in 2016 and headquartered in Al Iskandariyah, Egypt.

Investment focus

E-Commerce, Marketplace, Mobile Apps
Seed, Pre-Seed, Convertible Note
Egypt

Portfolio highlights

CardoO — Welcome To Our InnovationsExplore
SIDEUP — SIDEUP provides you with all the necessary tools to grow your business through a hassle-free experience from local and global logistics support, storage services, and innovative and real-time dashboards.
Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.

Global impact fund focusing on biotech, medtech and agritech investments that make a difference

Investment focus

Medical, Health Care, Life Science
Funding Round
Israel

Portfolio highlights

Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.

Investors by industry